Relieving the Emergency Department by Using a 1-lead ECG Device for Atrial Fibrillation Patients After Pulmonary Vein Isolation - Trial NCT06283654
Access comprehensive clinical trial information for NCT06283654 through Pure Global AI's free database. This phase not specified trial is sponsored by Amsterdam UMC, location VUmc and is currently Completed. The study focuses on Atrial Fibrillation. Target enrollment is 204 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Amsterdam UMC, location VUmc
Timeline & Enrollment
N/A
Sep 30, 2018
Jan 31, 2023
Primary Outcome
ED visits
Summary
In our study, we explored a new approach to manage atrial fibrillation, a disease that
 affects millions worldwide. Our goal was to see if using a simple handheld ECG device for
 monitoring heart rhythm could help patients avoid unnecessary visits to the emergency
 department (ED) after undergoing a common procedure known as pulmonary vein isolation (PVI).
 This procedure is often used to treat AF, but following it patients frequently visit the ED
 due to concerns about their heart rhythm, which can strain healthcare resources. We provided
 a group of patients with a 1-lead ECG device , which allows users to check their heart rhythm
 at any time. We compared the ED utilization over a year with that of patients who received
 standard care after PVI. Our hope was that by using the 1-lead ECG device, patients could
 better manage their condition from home and only seek medical help when truly necessary.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06283654
Device Trial